Jul 2026· Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis· Vol 168, pp.
108286
· 0 citations· 43 references
Medicine
TL;DR
The data indicate that MA4 alone drives aberrantly high expression of only a few target genes, whereas A4M counteracts this detrimental effect, and suggests that A4M is crucial through its chromatin-opening activity, which strongly expands the pool of MA4 target genes and thereby promotes the establishment of pre-leukemogenic and leukemogenic gene expression programs.
Abstract
The chromosomal translocation t(4;11)(q21;q23) is the most common genetic aberration in KMT2A-rearranged acute leukemia. Although the molecular functions of wild-type KMT2A and AFF1 complexes are well characterized, little is known about the interplay between the reciprocal fusion proteins KMT2A::AFF1 (MA4) and AFF1::KMT2A (A4M). Here, we established model systems to investigate this interplay and the role of the RNA-binding proteins IGF2BP1-3. We also compared the murinized fusion KMT2A::mAff1 (MmA4) with the authentic human KMT2A::AFF1 fusion. Our data indicate that MA4 alone drives aberrantly high expression of only a few target genes, whereas A4M counteracts this detrimental effect. Under these conditions, MA4 induces genes encoding RNA-binding proteins as a counterregulatory response. Both reciprocal fusion transcripts are bound by IGF2BP3, resulting in reduced MA4 protein abundance but increased A4M levels. This effect was not observed for the artificial MmA4 fusion, likely because it cannot recruit the SL-1 complex. Together with previous findings, our results suggest that A4M is crucial through its chromatin-opening activity, which strongly expands the pool of MA4 target genes and thereby promotes the establishment of pre-leukemogenic and leukemogenic gene expression programs.
The t(4;11) translocation, which drives KMT2A::AFF1 fusion gene expression, is associated with poor prognosis in pediatric and adult B-cell Acute Lymphoblastic Leukemia (B-ALL). KMT2A::AFF1 fusion circular RNAs (f-circRNAs) have been identified in B-ALL, though their contribution to leukemia has not yet been outlined....
D. Tolomeo, M. Bardini, Santina Venuto et al.· Haematologica· 0 citations
A genome-wide CRISPR/Cas9 screen in a KMT2Ar B-cell acute lymphoblastic leukemia cell line identified the deubiquitinase USP22 as a novel regulator of MEIS1 protein stability, that could potentially be exploited as a therapeutic target in the future in KMT2Ar leukemias.
Sarah Bröchtel, C. Schneider, Marius Müller et al.· Blood· 0 citations
Investigating the regulatory mechanism of the long non-coding RNA deoxyguanosine kinase antisense RNA 1 in LUAD reveals an m6A-dependent mechanism governing DGUOK-AS1 stability and provides insights into its contribution to LUAD progression.
Menghao Yang, Jia-En Wu, Youjie Li et al.· iScience· 0 citations
Enhanced activity in SF3B1-mutant cells suggests that simultaneous targeting of splicing and autophagy dependencies may represent a therapeutic strategy for SF3B1–mutant hematological malignancies, potentially driven by increased reliance on autophagy as a survival mechanism in this genetic context.
Mona Kazemi Sabzvar, Amol D. Patil, Eun Bee Cho et al.· Clinical Cancer Research· 0 citations
OtUD6B-AS1 suppresses EAC progression by sponging miR-145-5p and upregulating AIF to induce parthanatos activation, and Targeting this ceRNA regulatory axis may be a therapeutic strategy for EAC.
Qingfeng Zheng, Qiu-ping Wu, Yuling Lin et al.· American journal of translat...· 0 citations
INTRODUCTION
The t(2;11)(p21;q23) translocation without KMT2A rearrangement has been reported in ~16 hematologic neoplasms, but its molecular target(s) remain unknown. We aimed to identify the genes disrupted by this translocation and to clarify its contribution to Acute Myeloid Leukemia (AML) pathogenesis.
METHODS
W...
Shujun Li, Xiaoshan Yang, Peng Fang et al.· Current Medicinal Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.